CASIF

CASI Pharmaceuticals Inc (CASIF) Investor Questions

Review CASI Pharmaceuticals Inc (CASIF) faq with server-rendered company data, supporting context and links to related investor research.

Company
CASI Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Overall BTI score
35
Annual revenue
$20.71M
Annual net income
$-48.06M
Annual free cash flow
$-20.78M

CASI Pharmaceuticals Inc (CASIF) Investor Questions research

CASI Pharmaceuticals Inc trades under the ticker CASIF. The company is classified in the Healthcare sector and the Biotechnology industry.

Investors commonly review CASIF through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.